Key result
Intravenous glucagon increases heart rate, mean arterial pressure, and myocardial blood flow.
Why the study?
The effects of glucagon on the coronary circulation in humans were not well characterized.
Glucagon may augment coronary flow without arrhythmias in normals; leaves open differential effects and utility in ischemic or failing hearts.
Glucagon, 300 µg/ minute, was infused intravenously over 15 minutes in 27 subjects. The patients were divided into three groups: group I, patients without heart disease; group II, patients with arteriosclerotic heart disease; and group III, patients with congestive heart failure. Hemodynamic measurements included observations on myocardial blood flow using bolus injections of 84 rubidium and a coincidence counting technic. Myocardial oxygen consumption was determined after coronary sinus intubation in nine of the 27 patients. Significant increases were noted in heart rate, mean arterial pressure, tension-time index/minute and left ventricular work. Myocardial blood flow increased significantly while myocardial oxygen extraction remained constant suggesting that the augmentation in blood flow was sufficient to meet the increased myocardial demands for oxygen. The effects of glucagon on the coronary circulation resemble that of isoproterenol rather than norepinephrine without, however, leading to the production of arrhythmias seen with these catecholamines.
No takes yet. Share an insight, caveat, or question.
Goldschlager et al. (1969) studied Arteriosclerotic heart disease, congestive heart failure, or no heart disease (n=27). Glucagon was evaluated on Hemodynamic measurements and myocardial blood flow. Intravenous glucagon infusion significantly increased heart rate, mean arterial pressure, and myocardial blood flow while myocardial oxygen extraction remained constant.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: